Cover Image
市場調查報告書

糞便檢驗的全球市場:2015∼2019年

Global Gastrointestinal Stool Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 339929
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
糞便檢驗的全球市場:2015∼2019年 Global Gastrointestinal Stool Testing Market 2015-2019
出版日期: 2015年09月16日 內容資訊: 英文 61 Pages
簡介

糞便檢驗用於腸胃疾病診斷,用來檢測寄生蟲感染和發炎、出血、消化管和消化系統的腫瘤。還有也能用於大腸癌症檢查,加上輪狀病毒,腺病毒等病原菌的檢測。預計全球糞便檢驗市場2014∼2019年以年複合成長率7.37%擴大。

本報告提供全球糞便檢驗市場相關調查、市場現狀及至2019年的成長預測、市場規模、各用途趨勢、各地區趨勢,及主要供應商簡介彙整。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 償付與補償:概要

  • 目前方案:診斷檢驗的評估
  • 美國的報銷問題結構
  • EU的償付結構
  • 償付政策相關問題

第7章 糞便檢驗:現在及未來技術

第8章 各產品市場區隔

  • 試劑
  • 設備

第9章 各用途市場市場區隔

  • 大腸癌
  • 腹瀉
  • 消化管感染
  • 其他

第10章 各技術的市場區隔

第11章 各檢查的市場區隔

第12章 各地區的市場區隔

  • 各地區市場
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第13章 推動市場的要素

第14章 促進要素的影響

第15章 市場課題

第16章 促進要素與課題的影響

第17章 市場趨勢

第18章 供應商環境

  • 競爭模式
  • 主要供應商:2014年
  • 其他值得注意的供應商

第19章 主要供應商分析

  • Clinical Genomics
  • DiaSorin
  • Meridian Bioscience
  • Quidel

第20章 附錄

第21章 Technavio概要

圖表

目錄
Product Code: IRTNTR7243

About GI stool testing

Normal gastrointestinal (GI) functioning is essential for digestion as well as for the removal of body waste and pathogens. GI disorders are a common problem in the general population. These disorders are known to cause severe harm to the health and quality of life of an individual. These disorders include malabsorption disorders, inflammatory bowel diseases, cancer of the digestive system, colitis, and gastroenteritis. Globally, about 1.7-2 billion cases of diarrheal diseases occur every year. Also, about 1,700 million cases of C. difficile infections have been reported worldwide every year.

Stool tests are used for the diagnosis of GI disorders and help detect parasite infection, inflammation, bleeding obstruction, and tumors in the GI tract and digestive system. The diagnosis of GI diseases is commonly done through laboratory tests using antigen or culture detection from stool samples. A stool test is of two categories: fecal occult blood test (FOBT) and clinical microbiological stool tests. These tests are either antibody-based or microbial particle-based detection methods, which include immunoassay, CLIA, and molecular diagnostic testing. Stool tests are used for the screening of colorectal cancer as well as the detection of pathogens such as C. difficile, H. pylora, Rotavirus, and Adenovirus.

The global GI stool testing market is expected to grow at a CAGR of 7.37% during 2014-2019.

Covered in this report

In this report, Technavio covers the present scenario and growth prospects of the global GI stool testing market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of the following products:

  • FOBT
  • Clinical microbiology stool test

Technavio's report, Global GI Stool Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global BI and analytics platform market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Clinical Genomics
  • Diasorin
  • Meridian Bioscience
  • Quidel

Other Prominent Vendors

  • Alere
  • Beckman Coulter
  • bioMerieux
  • Bio-Rad Laboratories
  • CARE Products
  • Cenogenics
  • EIKEN CHEMICAL
  • Epigenomics
  • Epitope Diagnostic
  • Exact Sciences
  • Helena Laboratories
  • Hemosure
  • Mobidiag
  • Orion Diagnostica
  • Pinnacle BioLabs
  • Polymedco
  • Propper Manufacturing
  • ScheBo Biotech
  • Trinity Biotech

Key market driver

  • Increased incidence of C. difficile infections
  • For a full, detailed list, view our report

Key market challenge

  • Accurate diagnostic testing
  • For a full, detailed list, view our report

Key market trend

  • Focus on rapid and early diagnosis
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Reimbursement and coverage: An overview

  • Current scenario: Validating diagnostic tests
  • Reimbursement structure in the US
  • Reimbursement structure in EU
  • Prevailing issues of reimbursement policies

PART 07: Gastrointestinal stool tests: Present and future technology

PART 08: Market segmentation by product

  • Reagents
  • Instruments

PART 09: Market segmentation by application

  • Colorectal cancer
  • Diarrhea
  • Gastrointestinal tract infections
  • Others

PART 10: Market segmentation by technology

PART 11: Market segmentation by test

PART 12: Geographical segmentation

  • Global gastrointestinal stool testing market segmentation by geography
  • Gastrointestinal stool testing market in Americas
  • Gastrointestinal stool testing market in EMEA
  • Gastrointestinal stool testing market in APAC

PART 13: Market drivers

  • Increased incidence of Clostridium difficile infections
  • Automation and system integration
  • Early diagnosis of colorectal cancer
  • Focus on emerging countries

PART 14: Impact of drivers

PART 15: Market challenges

  • Accurate diagnostic testing
  • Business and regulatory issues
  • Alternatives to stool tests

PART 16: Impact of drivers and challenges

PART 17: Market trends

  • Rapid and early diagnosis
  • Use of point-of-care tests
  • Increase in public awareness

PART 18: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 19: Key vendor analysis

  • Clinical Genomics
  • DiaSorin
  • Meridian Bioscience
  • Quidel

PART 20: Appendix

  • List of abbreviations

PART 21: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global gastrointestinal stool testing market ($ millions)
  • Exhibit 03: Reimbursement perspectives of healthcare entities
  • Exhibit 04: Global gastrointestinal stool testing market segmentation by product
  • Exhibit 05: Global gastrointestinal stool testing market segmentation by product 2014
  • Exhibit 06: Global gastrointestinal stool testing market segmentation by application
  • Exhibit 07: Global gastrointestinal stool testing market segmentation by technology
  • Exhibit 08: Global gastrointestinal stool testing market segmentation by test
  • Exhibit 09: Global gastrointestinal stool testing market segmentation by geography 2014
  • Exhibit 10: Global gastrointestinal stool testing market segmentation by geography 2019
  • Exhibit 11: Global gastrointestinal stool testing market by geography 2014-2019
  • Exhibit 12: Gastrointestinal stool testing market in Americas ($ millions)
  • Exhibit 13: Gastrointestinal stool testing market in EMEA ($ millions)
  • Exhibit 14: Gastrointestinal stool testing market in APAC ($ millions)
  • Exhibit 15: Healthcare spending by country 2015 ($ billions)
  • Exhibit 16: Impact of drivers
  • Exhibit 17: Impact of drivers and challenges
  • Exhibit 18: Clinical Genomics: Key takeaways
  • Exhibit 19: DiaSorin: Key takeaways
  • Exhibit 20: Meridian Bioscience: Key takeaways
  • Exhibit 21: Quidel: Key takeaways
  • Exhibit 22: Clinical Genomics: Product categories
  • Exhibit 23: DiaSorin: Business segmentation by revenue 2014
  • Exhibit 24: DiaSorin: Business segmentation by revenue 2013 and 2014
  • Exhibit 25: DiaSorin: Geographical segmentation by revenue 2014
  • Exhibit 26: Meridian Bioscience: Business segmentation by revenue 2014
  • Exhibit 27: Meridian Bioscience: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 28: Meridian Bioscience: Geographical segmentation by revenue 2014
  • Exhibit 29: Quidel: Product segmentation by revenue 2014
  • Exhibit 30: Quidel: Product segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 31: Quidel: Geographical segmentation by revenue 2014
Back to Top